(Q43570683)

24 November 2017

Prognostic factors in 281 children with nonmetastatic rhabdomyosarcoma (RMS) at diagnosis (English)

1 reference

https://api.crossref.org/works/10.1002/MPO.2950160202

30 December 2022

1 reference

1 reference

https://api.crossref.org/works/10.1002/MPO.2950160202

30 December 2022

author name string

C. Rodary

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3352538

30 December 2022

A. Rey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3352538

30 December 2022

D. Olive

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3352538

30 December 2022

F. Flamant

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3352538

30 December 2022

E. Quintana

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3352538

30 December 2022

M. Brunat-Mentigny

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3352538

30 December 2022

J. Otten

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3352538

30 December 2022

P. A. Voute

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3352538

30 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3352538

30 December 2022

publication date

1 January 1988

1 reference

full work available at URL

24 November 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmpo.2950160202

1 reference

https://api.crossref.org/works/10.1002/MPO.2950160202

https://onlinelibrary.wiley.com/doi/full/10.1002/mpo.2950160202

30 December 2022

1 reference

https://api.crossref.org/works/10.1002/MPO.2950160202

30 December 2022

published in

Pediatric Blood Cancer

1 reference

Medical and Pediatric Oncology

24 November 2017

16

2

71–7

1988

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3352538

30 December 2022

volume

16

1 reference

24 November 2017

2

1 reference

24 November 2017

71-77

1 reference

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

24 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FMPO.2950160202

Childhood rhabdomyosarcoma: experience of the Children's Solid Tumour Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMPO.2950160202

Primary chemotherapy in the treatment of rhabdomyosarcoma in children: trial of the International Society of Pediatric Oncology (SIOP) preliminary results

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1002/MPO.2950160202

Prognosis in childhood rhabdomyosarcoma

30 December 2022

6

1 reference

https://api.crossref.org/works/10.1002/MPO.2950160202

Prognostic variables in pediatric rhabdomyosarcoma before and after multi-modal therapy

30 December 2022

7

1 reference

https://api.crossref.org/works/10.1002/MPO.2950160202

The improvement in survival associated with combined chemotherapy in childhood rhabdomyosarcoma. A historical comparison of 345 patients in the same center

30 December 2022

8

1 reference

https://api.crossref.org/works/10.1002/MPO.2950160202

Three-year relapse-free survival rates in childhood rhabdomyosarcoma of the head and neck: report from the Intergroup Rhabdomyosarcoma Study

30 December 2022

11

1 reference

https://api.crossref.org/works/10.1002/MPO.2950160202

Bladder and prostatic tumors in the intergroup Rhabdomyosarcoma study (IRS-I): results of therapy

30 December 2022

12

1 reference

https://api.crossref.org/works/10.1002/MPO.2950160202

Rhabdomyosarcoma: the Stanford experience using a TNM staging system

30 December 2022

14

1 reference

https://api.crossref.org/works/10.1002/MPO.2950160202

Multidisciplinary treatment of embryonal rhabdomyosarcoma in children

30 December 2022

16

1 reference

https://api.crossref.org/works/10.1002/MPO.2950160202

Statistical methods for the identification and use of prognostic factors

30 December 2022

17

1 reference

https://api.crossref.org/works/10.1002/MPO.2950160202

30 December 2022

Identifiers

1 reference

24 November 2017

1 reference